What I Bring to Industry
My career is defined by work that sits between academic discovery and commercial translation. I don't just generate publishable findings — I generate data packages, go/no-go recommendations, and strategic insights that move compounds through pipelines and inform investment decisions.
Evaluation of experimental rigor, mechanistic novelty, and translational potential across neurodegeneration, immunology, infectious disease, and rare genetic disease. Journal peer reviewer with track record assessing study claims against supporting data.
6+ years managing partnerships with Thermo Fisher, NysnoBio, GSK, SGC, and Abcam. CRO oversight through abmgood, Curia/Lake Pharma, Novogene, and Creative Diagnostics. Scope definition, milestone tracking, and go/no-go decision-making.
$1.5M+ in competitive grants from NIH/NINDS, MJFF, and private foundations. Budget oversight, milestone-based accountability, and familiarity with how funding decisions are structured — separating fundable proposals from unfundable ones.
Direct contribution to invention disclosures and patent specifications for small-molecule Parkin agonists. Exposure to IND-enabling workflows and FDA regulatory considerations through biopharma partnerships.